IDB-9389 · Biotech
At-Home Microbiome Test for IBS Patients
B2Cdiagnosticsgut
Opportunity score
76/100
graded across 14 signals
Momentum (90d)
↑ +18%
trailing 90 days
Market size (TAM)
$1.5B
primary US + global
Competition
HIGH
incumbents tracked
Difficulty
MEDIUM
technical + GTM
Time to market
5mo
to first revenue
Revenue model
Subscription
primary monetization
Search trend · trailing 24 weeks
Loading deep-dive…